Biogen (BIIB) EBITDA (2009 - 2026)
Biogen (BIIB) posted EBITDA of -$408.4 million for Q2 2026, compared with $333.3 million a year earlier.
Powered by 
Analysis
Biogen (BIIB) EBITDA (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Biogen was -$753.5 million; for FY2025, it came in at -$67.8 million.
- In prior years, Biogen's EBITDA was $268.8 million in FY2024, -$741.8 million in FY2023, $1.83 billion in FY2022 (-45.0%) and $3.33 billion in FY2021 (-33.5%).
- The Q2 2026 figure stands as the lowest quarterly EBITDA since Q3 2023.
- The strongest year-over-year quarter for EBITDA in the past five years was Q2 2022, with growth of 52.6%; the weakest was Q4 2022, with a decline of 78.8%.
- According to Business Quant data, EBITDA for the three prior quarters was -$78.9 million (Q1 2026), -$351.3 million (Q4 2025) and $85.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Biogen | 37.51 Bn | 24.16 Bn | 1.96 Bn | -408.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -408.40 Mn |
| Mar 31, 2026 | -78.90 Mn |
| Dec 31, 2025 | -351.30 Mn |
| Sep 30, 2025 | 85.10 Mn |
| Jun 30, 2025 | 333.30 Mn |
| Mar 31, 2025 | -134.90 Mn |
| Dec 31, 2024 | -108.00 Mn |
| Sep 30, 2024 | -4.90 Mn |
| Jun 30, 2024 | 311.60 Mn |
| Mar 31, 2024 | 70.10 Mn |
| Dec 31, 2023 | -186.60 Mn |
| Sep 30, 2023 | -675.80 Mn |
| Jun 30, 2023 | 232.80 Mn |
| Mar 31, 2023 | -112.20 Mn |
| Dec 31, 2022 | 152.70 Mn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 920.30 Mn |
| Mar 31, 2022 | 753.80 Mn |
| Dec 31, 2021 | 721.80 Mn |
| Sep 30, 2021 | 927.20 Mn |
API Access
Biogen EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();